{"PubmedBookArticle": [], "PubmedArticle": [{"MedlineCitation": {"OtherAbstract": [], "CitationSubset": ["IM"], "OtherID": [], "GeneralNote": [], "SpaceFlightMission": [], "KeywordList": [], "InvestigatorList": [], "PMID": "10433483", "DateCompleted": {"Year": "1999", "Month": "09", "Day": "14"}, "DateRevised": {"Year": "2019", "Month": "08", "Day": "31"}, "Article": {"Language": ["eng"], "ArticleDate": [], "ELocationID": [], "Journal": {"ISSN": "0378-8741", "JournalIssue": {"Volume": "66", "Issue": "2", "PubDate": {"Year": "1999", "Month": "Aug"}}, "Title": "Journal of ethnopharmacology", "ISOAbbreviation": "J Ethnopharmacol"}, "ArticleTitle": "Inhibition by berberine of cyclooxygenase-2 transcriptional activity in human colon cancer cells.", "Pagination": {"StartPage": "227", "EndPage": "233", "MedlinePgn": "227-33"}, "Abstract": {"AbstractText": ["The enzyme cyclooxygenase-2 (COX-2) is abundantly expressed in colon cancer cells and plays a key role in colon tumorigenesis. Compounds inhibiting COX-2 transcriptional activity have therefore potentially a chemopreventive property against colon tumor formation. An assay method for estimating COX-2 transcriptional activity in human colon cancer cells was established using a beta-galactosidase reporter gene system, and examination was made of various medicinal herbs and their ingredients for an inhibitory effect on COX-2 transcriptional activity. We found that berberine, an isoquinoline alkaloid present in plants of the genera Berberis and Coptis, effectively inhibits COX-2 transcriptional activity in colon cancer cells in a dose- and time-dependent manner at concentrations higher than 0.3 microM. The present findings may further explain the mechanism of anti-inflammatory and anti-tumor promoting effects of berberine."]}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Oriental Medicine, Gifu University School of Medicine, Japan. kfukuda@cc.gifu-u.ac.jp"}], "LastName": "Fukuda", "ForeName": "K", "Initials": "K"}, {"Identifier": [], "AffiliationInfo": [], "LastName": "Hibiya", "ForeName": "Y", "Initials": "Y"}, {"Identifier": [], "AffiliationInfo": [], "LastName": "Mutoh", "ForeName": "M", "Initials": "M"}, {"Identifier": [], "AffiliationInfo": [], "LastName": "Koshiji", "ForeName": "M", "Initials": "M"}, {"Identifier": [], "AffiliationInfo": [], "LastName": "Akao", "ForeName": "S", "Initials": "S"}, {"Identifier": [], "AffiliationInfo": [], "LastName": "Fujiwara", "ForeName": "H", "Initials": "H"}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "Ireland", "MedlineTA": "J Ethnopharmacol", "NlmUniqueID": "7903310", "ISSNLinking": "0378-8741"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Isoenzymes"}, {"RegistryNumber": "0", "NameOfSubstance": "Membrane Proteins"}, {"RegistryNumber": "0", "NameOfSubstance": "Protein Synthesis Inhibitors"}, {"RegistryNumber": "0I8Y3P32UF", "NameOfSubstance": "Berberine"}, {"RegistryNumber": "98600C0908", "NameOfSubstance": "Cycloheximide"}, {"RegistryNumber": "EC 1.14.99.1", "NameOfSubstance": "Cyclooxygenase 2"}, {"RegistryNumber": "EC 1.14.99.1", "NameOfSubstance": "PTGS2 protein, human"}, {"RegistryNumber": "EC 1.14.99.1", "NameOfSubstance": "Prostaglandin-Endoperoxide Synthases"}], "MeshHeadingList": [{"QualifierName": ["pharmacology"], "DescriptorName": "Berberine"}, {"QualifierName": ["drug effects"], "DescriptorName": "Cell Division"}, {"QualifierName": ["enzymology", "genetics"], "DescriptorName": "Colonic Neoplasms"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Cycloheximide"}, {"QualifierName": [], "DescriptorName": "Cyclooxygenase 2"}, {"QualifierName": ["drug effects"], "DescriptorName": "Genes, Reporter"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": ["biosynthesis", "genetics"], "DescriptorName": "Isoenzymes"}, {"QualifierName": [], "DescriptorName": "Membrane Proteins"}, {"QualifierName": [], "DescriptorName": "Plasmids"}, {"QualifierName": ["biosynthesis", "genetics"], "DescriptorName": "Prostaglandin-Endoperoxide Synthases"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Protein Synthesis Inhibitors"}, {"QualifierName": ["drug effects"], "DescriptorName": "Transcription, Genetic"}, {"QualifierName": [], "DescriptorName": "Transfection"}, {"QualifierName": [], "DescriptorName": "Tumor Cells, Cultured"}]}, "PubmedData": {"ReferenceList": [], "History": [{"Year": "1999", "Month": "8", "Day": "5"}, {"Year": "1999", "Month": "8", "Day": "5", "Hour": "0", "Minute": "1"}, {"Year": "1999", "Month": "8", "Day": "5", "Hour": "0", "Minute": "0"}], "PublicationStatus": "ppublish", "ArticleIdList": ["10433483", "10.1016/s0378-8741(98)00162-7", "S0378-8741(98)00162-7"]}}]}